For Referring Providers
The following information is for referring providers only.
Providers can initiate a request for treatment infusions for ambulatory patients with mild to moderate COVID-19 by completing the Beth Israel Lahey Health (BILH) COVID-19 Outpatient Therapeutics Referral Form. Referrals will be reviewed as rapidly as possible.
Providers can prescribe oral agents in respective EMRs directly and do NOT need to complete the referral form.
Providers should also consider COVID Therapeutics sites offered by Massachusetts Department of Public Health at Everett, Fall River, Holyoke, Lowell, Pittsfield, Athol, Plymouth, and select pharmacies. These sites offer all available treatment infusions and oral antiviral agents.
Alternatives to Nirmatrelvir with Ritonavir (Paxlovid)
For patients who are unable to receive nirmatrelvir with ritonavir (Paxlovid) due to significant medication interactions or other contraindications, remdesivir is also available at:
Providers with WebOMR Access (all three of the following must be completed):
- Place a WebOMR order for COVID-19 Ambulatory Treatment Scheduling.
- Place an order for remdesivir in the WebOMR Infusion/Pheresis Tab.
- Enter a note in WebOMR using the COVID-19 Ambulatory Therapy Referral Assessment Macro.
Providers without WebOMR Access:
- Complete a BIDMC COVID-19 Therapeutics Referral form and email to: covidmab@bidmc.harvard.edu or fax to 617-754-8861.
- A telehealth appointment with a BIDMC COVID-19 Therapeutics team provider will be required prior to patient scheduling.
Providers with LHMC Epic Access:
- Complete the Ambulatory Referral & Order for Outpatient COVID-19 Therapeutics in Epic. Follow the instructions in the order window.
Providers without LHMC Epic Access:
- Complete a LHMC COVID-19 Therapeutics Referral form and fax to 781-744-3657.
- A telehealth appointment with a LHMC provider will need to be completed prior to scheduling mAB treatment.
All providers:
- Complete the appropriate order form based on the therapy you are requesting for the patient.
- Fax the completed order form to 508-830-2789.
- Patients will then receive a call from Central Scheduling to coordinate their appointment and will be given directions for arrival.
Providers should also consider referral to the following:
- State-funded sites across Massachusetts provide oral provide oral and intravenous antiviral therapy.
- Massachusetts DPH in-home treatment program for individuals who qualify. Review eligibility requirements here.
COVID-19 Ambulatory Therapeutics Treatment at BID Plymouth
BID Plymouth serves as an ambulatory treatment site for the distribution of COVID-19 therapeutics. Providers can refer eligible patients by filling out the forms below. Please complete these forms and fax to BID Plymouth at 508-830-2789 to initiate a referral.